The global market for Semi-Solid Formulations Drug Delivery was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The semi-solid drug category is comprised of creams, gels, ointments, suppositories, and other special topical dosage forms. Semi-solid drug formulations share many common attributes which include consistency, dosage uniformity, preservatives, the route of administration and their formulation basis.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Semi-Solid Formulations Drug Delivery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Semi-Solid Formulations Drug Delivery.
The Semi-Solid Formulations Drug Delivery market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Semi-Solid Formulations Drug Delivery market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Semi-Solid Formulations Drug Delivery companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Glenmark Pharmaceuticals
Galderma
Johnson & Johnson Private
GlaxoSmithKline
Bausch Health Companies
Hisamitsu Pharmaceuticals
Cipla
Bayer
Viatris
3M
Merck & Co
Crescita Therpeautics
Novartis International
Boehringer Ingelheim
Pfizer
Teva Pharmaceuticals
Bristol Myers Squibb
Lead Chemical
Purdue Pharma
Segment by Type
Creams
Ointments
Lotions
Gel
Pastes
Segment by Application
Home Care Settings
Hospitals & Clinics
Burn Centers
Other Facilities
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Semi-Solid Formulations Drug Delivery company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Semi-Solid Formulations Drug Delivery Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Creams
1.2.3 Ointments
1.2.4 Lotions
1.2.5 Gel
1.2.6 Pastes
1.3 Market by Application
1.3.1 Global Semi-Solid Formulations Drug Delivery Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Home Care Settings
1.3.3 Hospitals & Clinics
1.3.4 Burn Centers
1.3.5 Other Facilities
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Semi-Solid Formulations Drug Delivery Market Perspective (2020-2031)
2.2 Global Semi-Solid Formulations Drug Delivery Growth Trends by Region
2.2.1 Global Semi-Solid Formulations Drug Delivery Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Semi-Solid Formulations Drug Delivery Historic Market Size by Region (2020-2025)
2.2.3 Semi-Solid Formulations Drug Delivery Forecasted Market Size by Region (2026-2031)
2.3 Semi-Solid Formulations Drug Delivery Market Dynamics
2.3.1 Semi-Solid Formulations Drug Delivery Industry Trends
2.3.2 Semi-Solid Formulations Drug Delivery Market Drivers
2.3.3 Semi-Solid Formulations Drug Delivery Market Challenges
2.3.4 Semi-Solid Formulations Drug Delivery Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Semi-Solid Formulations Drug Delivery Players by Revenue
3.1.1 Global Top Semi-Solid Formulations Drug Delivery Players by Revenue (2020-2025)
3.1.2 Global Semi-Solid Formulations Drug Delivery Revenue Market Share by Players (2020-2025)
3.2 Global Semi-Solid Formulations Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Semi-Solid Formulations Drug Delivery Revenue
3.4 Global Semi-Solid Formulations Drug Delivery Market Concentration Ratio
3.4.1 Global Semi-Solid Formulations Drug Delivery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Semi-Solid Formulations Drug Delivery Revenue in 2024
3.5 Global Key Players of Semi-Solid Formulations Drug Delivery Head office and Area Served
3.6 Global Key Players of Semi-Solid Formulations Drug Delivery, Product and Application
3.7 Global Key Players of Semi-Solid Formulations Drug Delivery, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Semi-Solid Formulations Drug Delivery Breakdown Data by Type
4.1 Global Semi-Solid Formulations Drug Delivery Historic Market Size by Type (2020-2025)
4.2 Global Semi-Solid Formulations Drug Delivery Forecasted Market Size by Type (2026-2031)
5 Semi-Solid Formulations Drug Delivery Breakdown Data by Application
5.1 Global Semi-Solid Formulations Drug Delivery Historic Market Size by Application (2020-2025)
5.2 Global Semi-Solid Formulations Drug Delivery Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Semi-Solid Formulations Drug Delivery Market Size (2020-2031)
6.2 North America Semi-Solid Formulations Drug Delivery Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Semi-Solid Formulations Drug Delivery Market Size by Country (2020-2025)
6.4 North America Semi-Solid Formulations Drug Delivery Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Semi-Solid Formulations Drug Delivery Market Size (2020-2031)
7.2 Europe Semi-Solid Formulations Drug Delivery Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Semi-Solid Formulations Drug Delivery Market Size by Country (2020-2025)
7.4 Europe Semi-Solid Formulations Drug Delivery Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Semi-Solid Formulations Drug Delivery Market Size (2020-2031)
8.2 Asia-Pacific Semi-Solid Formulations Drug Delivery Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Semi-Solid Formulations Drug Delivery Market Size by Region (2020-2025)
8.4 Asia-Pacific Semi-Solid Formulations Drug Delivery Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Semi-Solid Formulations Drug Delivery Market Size (2020-2031)
9.2 Latin America Semi-Solid Formulations Drug Delivery Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Semi-Solid Formulations Drug Delivery Market Size by Country (2020-2025)
9.4 Latin America Semi-Solid Formulations Drug Delivery Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Semi-Solid Formulations Drug Delivery Market Size (2020-2031)
10.2 Middle East & Africa Semi-Solid Formulations Drug Delivery Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Semi-Solid Formulations Drug Delivery Market Size by Country (2020-2025)
10.4 Middle East & Africa Semi-Solid Formulations Drug Delivery Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Glenmark Pharmaceuticals
11.1.1 Glenmark Pharmaceuticals Company Details
11.1.2 Glenmark Pharmaceuticals Business Overview
11.1.3 Glenmark Pharmaceuticals Semi-Solid Formulations Drug Delivery Introduction
11.1.4 Glenmark Pharmaceuticals Revenue in Semi-Solid Formulations Drug Delivery Business (2020-2025)
11.1.5 Glenmark Pharmaceuticals Recent Development
11.2 Galderma
11.2.1 Galderma Company Details
11.2.2 Galderma Business Overview
11.2.3 Galderma Semi-Solid Formulations Drug Delivery Introduction
11.2.4 Galderma Revenue in Semi-Solid Formulations Drug Delivery Business (2020-2025)
11.2.5 Galderma Recent Development
11.3 Johnson & Johnson Private
11.3.1 Johnson & Johnson Private Company Details
11.3.2 Johnson & Johnson Private Business Overview
11.3.3 Johnson & Johnson Private Semi-Solid Formulations Drug Delivery Introduction
11.3.4 Johnson & Johnson Private Revenue in Semi-Solid Formulations Drug Delivery Business (2020-2025)
11.3.5 Johnson & Johnson Private Recent Development
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Details
11.4.2 GlaxoSmithKline Business Overview
11.4.3 GlaxoSmithKline Semi-Solid Formulations Drug Delivery Introduction
11.4.4 GlaxoSmithKline Revenue in Semi-Solid Formulations Drug Delivery Business (2020-2025)
11.4.5 GlaxoSmithKline Recent Development
11.5 Bausch Health Companies
11.5.1 Bausch Health Companies Company Details
11.5.2 Bausch Health Companies Business Overview
11.5.3 Bausch Health Companies Semi-Solid Formulations Drug Delivery Introduction
11.5.4 Bausch Health Companies Revenue in Semi-Solid Formulations Drug Delivery Business (2020-2025)
11.5.5 Bausch Health Companies Recent Development
11.6 Hisamitsu Pharmaceuticals
11.6.1 Hisamitsu Pharmaceuticals Company Details
11.6.2 Hisamitsu Pharmaceuticals Business Overview
11.6.3 Hisamitsu Pharmaceuticals Semi-Solid Formulations Drug Delivery Introduction
11.6.4 Hisamitsu Pharmaceuticals Revenue in Semi-Solid Formulations Drug Delivery Business (2020-2025)
11.6.5 Hisamitsu Pharmaceuticals Recent Development
11.7 Cipla
11.7.1 Cipla Company Details
11.7.2 Cipla Business Overview
11.7.3 Cipla Semi-Solid Formulations Drug Delivery Introduction
11.7.4 Cipla Revenue in Semi-Solid Formulations Drug Delivery Business (2020-2025)
11.7.5 Cipla Recent Development
11.8 Bayer
11.8.1 Bayer Company Details
11.8.2 Bayer Business Overview
11.8.3 Bayer Semi-Solid Formulations Drug Delivery Introduction
11.8.4 Bayer Revenue in Semi-Solid Formulations Drug Delivery Business (2020-2025)
11.8.5 Bayer Recent Development
11.9 Viatris
11.9.1 Viatris Company Details
11.9.2 Viatris Business Overview
11.9.3 Viatris Semi-Solid Formulations Drug Delivery Introduction
11.9.4 Viatris Revenue in Semi-Solid Formulations Drug Delivery Business (2020-2025)
11.9.5 Viatris Recent Development
11.10 3M
11.10.1 3M Company Details
11.10.2 3M Business Overview
11.10.3 3M Semi-Solid Formulations Drug Delivery Introduction
11.10.4 3M Revenue in Semi-Solid Formulations Drug Delivery Business (2020-2025)
11.10.5 3M Recent Development
11.11 Merck & Co
11.11.1 Merck & Co Company Details
11.11.2 Merck & Co Business Overview
11.11.3 Merck & Co Semi-Solid Formulations Drug Delivery Introduction
11.11.4 Merck & Co Revenue in Semi-Solid Formulations Drug Delivery Business (2020-2025)
11.11.5 Merck & Co Recent Development
11.12 Crescita Therpeautics
11.12.1 Crescita Therpeautics Company Details
11.12.2 Crescita Therpeautics Business Overview
11.12.3 Crescita Therpeautics Semi-Solid Formulations Drug Delivery Introduction
11.12.4 Crescita Therpeautics Revenue in Semi-Solid Formulations Drug Delivery Business (2020-2025)
11.12.5 Crescita Therpeautics Recent Development
11.13 Novartis International
11.13.1 Novartis International Company Details
11.13.2 Novartis International Business Overview
11.13.3 Novartis International Semi-Solid Formulations Drug Delivery Introduction
11.13.4 Novartis International Revenue in Semi-Solid Formulations Drug Delivery Business (2020-2025)
11.13.5 Novartis International Recent Development
11.14 Boehringer Ingelheim
11.14.1 Boehringer Ingelheim Company Details
11.14.2 Boehringer Ingelheim Business Overview
11.14.3 Boehringer Ingelheim Semi-Solid Formulations Drug Delivery Introduction
11.14.4 Boehringer Ingelheim Revenue in Semi-Solid Formulations Drug Delivery Business (2020-2025)
11.14.5 Boehringer Ingelheim Recent Development
11.15 Pfizer
11.15.1 Pfizer Company Details
11.15.2 Pfizer Business Overview
11.15.3 Pfizer Semi-Solid Formulations Drug Delivery Introduction
11.15.4 Pfizer Revenue in Semi-Solid Formulations Drug Delivery Business (2020-2025)
11.15.5 Pfizer Recent Development
11.16 Teva Pharmaceuticals
11.16.1 Teva Pharmaceuticals Company Details
11.16.2 Teva Pharmaceuticals Business Overview
11.16.3 Teva Pharmaceuticals Semi-Solid Formulations Drug Delivery Introduction
11.16.4 Teva Pharmaceuticals Revenue in Semi-Solid Formulations Drug Delivery Business (2020-2025)
11.16.5 Teva Pharmaceuticals Recent Development
11.17 Bristol Myers Squibb
11.17.1 Bristol Myers Squibb Company Details
11.17.2 Bristol Myers Squibb Business Overview
11.17.3 Bristol Myers Squibb Semi-Solid Formulations Drug Delivery Introduction
11.17.4 Bristol Myers Squibb Revenue in Semi-Solid Formulations Drug Delivery Business (2020-2025)
11.17.5 Bristol Myers Squibb Recent Development
11.18 Lead Chemical
11.18.1 Lead Chemical Company Details
11.18.2 Lead Chemical Business Overview
11.18.3 Lead Chemical Semi-Solid Formulations Drug Delivery Introduction
11.18.4 Lead Chemical Revenue in Semi-Solid Formulations Drug Delivery Business (2020-2025)
11.18.5 Lead Chemical Recent Development
11.19 Purdue Pharma
11.19.1 Purdue Pharma Company Details
11.19.2 Purdue Pharma Business Overview
11.19.3 Purdue Pharma Semi-Solid Formulations Drug Delivery Introduction
11.19.4 Purdue Pharma Revenue in Semi-Solid Formulations Drug Delivery Business (2020-2025)
11.19.5 Purdue Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
Glenmark Pharmaceuticals
Galderma
Johnson & Johnson Private
GlaxoSmithKline
Bausch Health Companies
Hisamitsu Pharmaceuticals
Cipla
Bayer
Viatris
3M
Merck & Co
Crescita Therpeautics
Novartis International
Boehringer Ingelheim
Pfizer
Teva Pharmaceuticals
Bristol Myers Squibb
Lead Chemical
Purdue Pharma
听
听
*If Applicable.
